LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 190 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,336,000 | +106.5% | 9,843 | +215.0% | 0.07% | +200.0% |
| Q2 2018 | $647,000 | -12.0% | 3,125 | -56.8% | 0.02% | -23.3% |
| Q4 2016 | $735,000 | +51.2% | 7,234 | -20.8% | 0.03% | +87.5% |
| Q4 2014 | $486,000 | +50.0% | 9,130 | +32.5% | 0.02% | +60.0% |
| Q3 2014 | $324,000 | -71.0% | 6,892 | -61.6% | 0.01% | -66.7% |
| Q2 2014 | $1,118,000 | +117.9% | 17,953 | +135.6% | 0.03% | +114.3% |
| Q1 2014 | $513,000 | – | 7,620 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |